Study reveals best drug dose for obese patients with rare brain infection
NCT ID NCT05127395
First seen Mar 23, 2026 · Last updated May 15, 2026 · Updated 6 times
Summary
This study looked back at medical records of 50 obese adults with HSV encephalitis (a rare brain infection caused by the herpes virus) to see how different ways of calculating acyclovir doses affected their outcomes. Researchers compared dosing based on ideal body weight versus adjusted body weight. The goal was to find the safest and most effective dosing method for this group.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HSV ENCEPHALITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Methodist Charlton Medical Center
Dallas, Texas, 75237, United States
Conditions
Explore the condition pages connected to this study.